Therapeutic Proteins
DOI: 10.1385/1-59259-922-2:381
|View full text |Cite
|
Sign up to set email alerts
|

Oligosaccharide Release and MALDI-TOF MS Analysis of N-Linked Carbohydrate Structures from Glycoproteins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
16
0

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(16 citation statements)
references
References 14 publications
0
16
0
Order By: Relevance
“…Selected samples were confirmed using a well-established matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometric glycan characterization assay. 35,36 In the rpHPLC ESI-MS method, the distribution of glycans attached to the antibody was deduced from the overall mass of the heavy chain with its associated N-glycan. This method does not require release of glycan using N-glycosidase F (PNGaseF), 35,36 thereby allowing rapid characterization of the antibody glycoform.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Selected samples were confirmed using a well-established matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometric glycan characterization assay. 35,36 In the rpHPLC ESI-MS method, the distribution of glycans attached to the antibody was deduced from the overall mass of the heavy chain with its associated N-glycan. This method does not require release of glycan using N-glycosidase F (PNGaseF), 35,36 thereby allowing rapid characterization of the antibody glycoform.…”
Section: Discussionmentioning
confidence: 99%
“…35,36 In the rpHPLC ESI-MS method, the distribution of glycans attached to the antibody was deduced from the overall mass of the heavy chain with its associated N-glycan. This method does not require release of glycan using N-glycosidase F (PNGaseF), 35,36 thereby allowing rapid characterization of the antibody glycoform. To prepare the samples for analysis, 0.1 to 0.5 mg of antibody was mixed with a 1:1 (w/w) ratio of reducing agent tris(2-carboxyethyl)phosphine hydrochloride (TCEP) and solvent (10% acetonitrile/0.1% formic acid/HPLC-grade water) to reach a final antibody concentration of 0.5-1 mg/mL.…”
Section: Discussionmentioning
confidence: 99%
“…Samples were acidified with glacial acetic acid and desalted using a Dowex 50X8 cation-exchange resin spin column (25). O-Glycans were collected in the flow-through.…”
Section: Cells Transfections and Fusion Proteins-genbankmentioning
confidence: 99%
“…Permethylated glycans were cleaned via solid phase extraction on a vacuum-driven Hypersep C18 10-mg cartridge (Thermo Scientific), followed by repeated washes with water and 5% aqueous solution of acetonitrile, and elution with a 75% aqueous solution of acetonitrile. For MALDI-TOF MS analysis, 1 l of permethylated glycans was spotted on the stainless steel target, followed by 1 l of "super 2,5-dihydroxybenzoic acid" matrix, and samples were briefly dried using vacuum (25). Spectra were acquired in a positive mode on a Bruker UltraFlex MALDI-TOF/TOF instrument and calibrated with permethylated glucose homopolymer mixture (ProZyme).…”
Section: Cells Transfections and Fusion Proteins-genbankmentioning
confidence: 99%
“…This would allow increased profiling of antibodies from multiple cell lines during culture and facilitate better optimization of production processes to make quality integral to the system, a facet which is essential for process analytical technology (PAT). Methods have been published for the analysis of glycans in multi-well formats using PVDF coated 96-well plates for the non-specific capture and concentration of protein (Keck et al, 2005;Papac et al, 1998). The workflows described below enable the specific purification and concentration of the antibody prior to glycan analysis.…”
mentioning
confidence: 99%